9 Comments
User's avatar
Ozeco's avatar

Loved this article and your nuanced view!

Jodi Ware's avatar

Good observations re: Librela, Sir! 🫡

Best Anchor Stocks's avatar

What's incredible is that this only happens in the US but has not been a concern in Europe? Rare!

Jodi Ware's avatar

The majority of cases in and authors of this article are from Europe.

Best Anchor Stocks's avatar

And yet you have Librela penetrating mild cases in Europe which would 100% not be the case if adverse effects were so widespread.

Jodi Ware's avatar

I encourage you to read the full article (including supplementary materials).

James's avatar

First off, amazing write up really appreciate your knowledge. One question for you: why has ZTS current ratio dropped the last 2 quarters? Was it accelerated buybacks as a result of share price declines?